Powered by lexis nexis

Semma Therapeutics attracts funding

Mar 22, 2017 - peHUB

Cambridge, Massachusetts-based Semma Therapeutics, a developer of cell therapy for Type 1 diabetes, has raised an undisclosed amount of funding. The investor was JDRF T1D Fund, a venture philanthropy fund.

PRESS RELEASE

BOSTON, MA – March 22, 2017 – Semma Therapeutics, a biopharmaceutical company developing Stem Cell-derived Islet therapy for type 1 diabetes (T1D), today announced it has received an investment from the JDRF T1D Fund, a venture philanthropy fund exclusively devote...

Check out News Home to stay on top of the people and organizations you care most about.
Mentioned Entities
Semma Therapeutics, Inc.
Robert A. Millman
Check out News Home to stay on top of the people and organizations you care most about.
Mentioned Entities
Semma Therapeutics, Inc.
Robert A. Millman
Also check out:
Most Connected Accounting and Financial Services Executives How to Make a Good Impression on Venture Capitalists - Relationship Science Business Leaders Share the Best Networking Tips They've Ever Receiv...